| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AZD0530 | CTRPv2 | pan-cancer | AAC | -0.0045 | 0.9 |
| mRNA | Cytarabine | FIMM | pan-cancer | AAC | 0.022 | 0.9 |
| mRNA | AC220 | GDSC1000 | pan-cancer | AAC | 0.0041 | 0.9 |
| mRNA | BRD-K97651142 | CTRPv2 | pan-cancer | AAC | -0.0044 | 0.9 |
| mRNA | A-443654 | GDSC1000 | pan-cancer | AAC | 0.0055 | 0.9 |
| mRNA | MPS-1-IN-1 | GDSC1000 | pan-cancer | AAC | -0.0033 | 0.9 |
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | 0.0048 | 0.9 |
| mRNA | MP470 | GDSC1000 | pan-cancer | AAC | -0.0034 | 0.9 |
| mRNA | fulvestrant | CTRPv2 | pan-cancer | AAC | -0.0075 | 0.9 |
| mRNA | sitagliptin | CTRPv2 | pan-cancer | AAC | -0.0069 | 0.9 |